Method for isolating cells expressing flk-2
Patent Number: 6960446
Date of First Priority Issue: Monday February 4th, 1991
Date Issued: Tuesday January 11th, 2005
Assignee: The Trustees of Princeton University (Princeton, NJ)
Inventor: Lemischka, Ihor R. (Princeton, NJ)
From Class: Extraction/Preservation
Comments: No comments
fetal liver kinase 2 (flk-2) is expressed on numerous types of stem cells. This patent covers isolation of cells expressing this marker using either a monoclonal or polyclonal antibody. The patent has 1 independent claim which essentially covers the subject matter previously mentioned. The importance of flk-2 on hematopoietic stem cells was published by the author (Matthews W, et al. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991 Jun 28;65(7):1143-52)
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.